CERVICAL CANCER

Nano-biotechnology how far away from clinical clinics

Nano-biotechnology in clinical applications in the foreseeable future will be very extensive. Over the past 10 years, the use of nanotechnology for the early diagnosis and treatment of malignant tumors of exploration and research in the Western developed countries in full swing, the United States, Japan, Germany and other developed countries investing in the study, the aim of conquering cancer 15 years.

Long-term scientific research and medical practice has been recognized, cervical cancer is transmitted through sexual life of a disease. Its incidence of the following four factors are closely related:

(1) women's cervix recurring inflammation, erosion, leukoplakia, polyps and vaginal trichomoniasis, mold and other factors;
(2) male genitalia have long foreskin and the existence 20/48;
3. Male or female sexual partners over the life history;
(4) female reproductive system infection history, in particular the high-risk HPV infection are continuing.

The incidence of cervical cancer model: D cervical erosion of low D squamous intraepithelial lesions moderate squamous intraepithelial lesions D highly squamous intraepithelial lesions → minimal invasive carcinoma DCIS → → invasive carcinoma

Cervical cancer is the second only to breast cancer in women in the world's second most common malignancy, women accounted for more than half of genital cancer, 95% for squamous cell carcinoma, adenocarcinoma of around 4%, there are other sarcoma, lymphoma, malignant melanoma and other. World cervical cancer incidence varies widely in developing countries, particularly in Central America, South America, Southeast Asia, India, Eastern Europe and the higher incidence. A conservative approach to sex countries such as Spain, Ireland, Kuwait and Israel, the incidence of cervical cancer was low. The incidence rate is the lowest in Australia, New Zealand, Southern Europe, North America and the Middle East. According to reports, in the new world of cervical cancer each year 46.5 million people die each year more than 200,000 people.

Also known as endometrial carcinoma of uterine cancer, endometrial cancer. Its high for the age 58 to 61 years, women accounted for 7% of the total cancer, cancer of the female reproductive tract for 20% to 30%, with higher incidence of low cure rate and advanced features. The following are some possible to endometrial cancer factors, hope to draw attention.

According to history and clinical performance, especially with bleeding, should first think of a possible cervical cancer, should do a detailed body check and gynecological examinations, and the following examinations:

(1) scratch cervical cytology screening is found early cervical lesions and early cervical cancer main methods. But attention to the correct location and examination material carefully, 5% ~ 10% false negative rate, it should be combined with clinical, and periodic examinations, screening for this method.

Cervical cancer is the most common of women genital tumors, but also the threat of an important women's health diseases, and radiation therapy of cervical cancer is the primary means of intracavitary radiation therapy after loading including radiotherapy and radiotherapy treatment.

After loading radiotherapy is the first non-radioactive sources at the treatment site for containers, and then into containers for radioactive sources, such treatment can be avoided placing containers in the process of medical personnel from unnecessary exposure.
Before treatment care

(1) tumor marker

Cervical cancer in women worldwide after breast cancer is the second common malignancy. Women in developing countries in which the incidence of one. According to the International Cancer Research Center (CC) in its five-year estimate of 1.558 million cases of relief, 100 million in developing countries, 30 million in developed countries. Parkin report of the 1980s the number of cervical cancer worldwide each of the 46.5 million women of the new cancer cases 15%, 3 / 4 in developing countries. Worldwide every year, over 20 million women die of cervical cancer, the cause of death of women in Latin America, 25% of malignant tumors, of which 18 per 1,000 deaths from cervical cancer (WHO, 1986). Every year 131,500 new cases for. In the 1970s the mortality rate for cervical cancer in China 9.98/10 10,000, the annual death toll at 53,000, the number of female cancer deaths 18.4%, second only to stomach cancer. From 1990 to 1992 the death rate from cervical cancer 3.25/10 million cancer death in women in the composition of 4.86%, ranking sixth. China's Taiwan Province in 1994 at 9.54/10 10,000 cervical cancer mortality, the death toll is 973, second only to lung cancer and liver cancer, cancer death in women being the third.

Experience with
1). To understand the pathogenesis of cervical cancer, take corresponding measures to promote Late marriage, family planning, cervical Shanghai women actively control the disease, tumor uphold the census work, we will be able to reduce the incidence of cervical cancer. Due to the early detection of tumors census pre-cancerous lesions and carcinoma in situ, the cure rate significantly effective treatment to improve, thereby reducing cervical cancer invasion and has played a significant role.

2). Chinese medicine is better for cervical cancer, especially in the early stages of cervical cancer in Chinese medicine and the main local drug Syndrome Treatment of Oral medicine secondary treatment.

An outline
Cervical cancer occurs in the cervical cancer in women.
Women in the abdominal hysterectomy is a range between the bladder and rectum, hollow organs. The uterine cervix in the second half which is a narrow part of the cervix, cervical openings on the female vagina. Its function is to menstrual outflow channel is vaginal microorganisms and air to enter the uterus of a female barrier, and also subject to sexual intercourse can withstand the induced inflammatory response.